osteoarthritis

fired layoffs cut executives dismissed
Biotech

Kolon TissueGene shrinks workforce after pivotal trial miss

Following a ph. 3 knee failure that its CEO acknowledged caused “great disappointment and concern,” TissueGene is laying off 37 Maryland employees.
Darren Incorvaia Aug 18, 2026 4:00pm
Knee arthritis osteoarthritis

Kolon’s cell-based gene therapy fails ph.3 osteoarthritis test

Jul 20, 2026 9:25am
obesity overweight weight loss weigh

Lilly's obesity triple threat tops phase 3 efficacy forecasts

Dec 11, 2025 8:15am
Red stop sign on road

Eli Lilly sidelines pain prospect in another pipeline shift

Oct 30, 2025 2:19pm
Broom sweep clean

Novartis axes osteoarthritis asset and radioligand therapy

Apr 29, 2025 5:24am
X ray illustration of a running person with pain in knee joint with blue background

Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset

Apr 16, 2025 2:55pm